OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 73 filers reported holding OVID THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $26,040 | -23.4% | 14,000 | -23.5% | 0.00% | – |
| Q3 2022 | $34,000 | -33.3% | 18,300 | -23.1% | 0.00% | – |
| Q2 2022 | $51,000 | -52.8% | 23,800 | -30.8% | 0.00% | – |
| Q1 2022 | $108,000 | -28.5% | 34,400 | -27.0% | 0.00% | – |
| Q4 2021 | $151,000 | -58.4% | 47,100 | -56.4% | 0.00% | -100.0% |
| Q3 2021 | $363,000 | -72.1% | 108,000 | -67.5% | 0.00% | -66.7% |
| Q2 2021 | $1,299,000 | +1.1% | 332,200 | +3.9% | 0.00% | -25.0% |
| Q1 2021 | $1,285,000 | -6.3% | 319,600 | -46.1% | 0.00% | 0.0% |
| Q4 2020 | $1,371,000 | +42.1% | 593,400 | +252.8% | 0.00% | +33.3% |
| Q3 2020 | $965,000 | +1278.6% | 168,200 | +618.8% | 0.00% | – |
| Q1 2020 | $70,000 | -12.5% | 23,400 | +21.9% | 0.00% | – |
| Q4 2019 | $80,000 | – | 19,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
| Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
| BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
| CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
| EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
| Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
| Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
| Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
| DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |